Scar carcinoma of the lung: a historical perspective.
Bobba RK, Holly JS, Loy T, Perry MC.
Clin Lung Cancer. 2011 May;12(3):148-54. doi: 10.1016/j.cllc.2011.03.011. Epub 2011 Apr 24.
New progress of tuberculosis scar carcinoma.
Sun W, Liu Y, Zhao L, Wang H, Ye L, Liu X, Xu K, Chen Y, Fan L.
Cancer Metastasis Rev. 2023 Sep;42(3):653-659. doi: 10.1007/s10555-023-10128-9. Epub 2023 Aug 16.
Occult scar carcinoma of the lung with overt liver metastases and high serum CA 19-9 levels.
Lin YY, Cho SF.
J Postgrad Med. 2019 Oct-Dec;65(4):251-252. doi: 10.4103/jpgm.JPGM_145_19.
Collagens in scar carcinoma of the lung.
el-Torkey M, Giltman LI, Dabbous M.
Am J Pathol. 1985 Nov;121(2):322-6.
The development and progression of adenocarcinoma of the lung.
Noguchi M, Shimosato Y.
Cancer Treat Res. 1995;72:131-42. doi: 10.1007/978-1-4615-2630-8_6.
Scar carcinoma of the lung. Fact or fantasy?
Freant LJ, Joseph WL, Adkins PC.
Ann Thorac Surg. 1974 Jun;17(6):531-7. doi: 10.1016/s0003-4975(10)65693-7.
Prognostic significance of microscopic size in peripherally located scar-associated clinical stage I lung carcinomas.
Trejo Bittar HE, Jerome JA, Hartman D, Pantanowitz L, Mehrad M, Dacic S.
Lung Cancer. 2020 May;143:12-18. doi: 10.1016/j.lungcan.2020.03.004. Epub 2020 Mar 7.
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnissen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M.
J Thorac Oncol. 2006 Nov;1(9 Suppl):S13-9.
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.
Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnisen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M.
J Clin Oncol. 2005 May 10;23(14):3279-87. doi: 10.1200/JCO.2005.15.776.
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Krause M, Stenbygaard L, Mjaaland I, Schreiber A, Kasti UM, Overgaard J; Danish Breast Cancer Group Radiation Therapy Committee.
J Clin Oncol. 2020 Nov 1;38(31):3615-3625. doi: 10.1200/JCO.20.01363. Epub 2020 Sep 10.
